January 2000
VDR GENOTYPES PREDICT BONE DENSITY IN PBC 151
pathogenesis, risk factors, and management. Dig Dis 1994;12:
23–231.
2. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN,
Eberl S. Genetic determinants of bone mass in adults: a twin
study. J Clin Invest 1987;80:706–710.
3. Morrison NA, Qi JC, Tokita A, Kelly P, Crofts L, Nguyen TV,
Sambrook PN, Eisman J. Prediction of bone density from vitamin
D receptor alleles. Nature 1994;367:284–287.
31. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs
BL. Role of hyperbilirubinemia in the impairment of osteoblast
proliferation associated with cholestatic jaundice. J Clin Invest
1995;95:2581–2586.
32. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK,
Wahner HW, Cedel, SL, Riggs BL, Krom RAF. Rates of vertebral
bone loss before and after liver transplantation in women with
primary biliary cirrhosis. Hepatology 1991;14:296–300.
2
1
1
1
1
1
1
4. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms
associated with bone mineral density? A meta-analysis. J Bone
Miner Res 1996;12:1841–1849.
3
3
3
3. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD. Hepatic
osteodystrophy in primary biliary cirrhosis: effects of medical
treatment. Am J Gastroenterol 1994;89:47–50.
4. Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Bone
disease in primary biliary cirrhosis: does ursodeoxycholic acid
make a difference? Hepatology 1995;21:389–392.
5. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O’Rourke K, Bailey
RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ,
Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ. Is the
mayo model for predicting survival useful after the introduction of
ursodeoxycholic acid treatment for primary biliary cirrhosis?
Hepatology 1996;23:1148–1153.
6. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnson CC.
Genetic determinants of bone mass in adult women: a reevalua-
tion of the twin model and the potential importance of gene
interaction on heritability estimates. J Bone Miner Res 1991;6:
5. Gross C, Eccleshall TR, Feldman D. Vitamin D receptor alleles and
osteoporosis. In: Bilizekian JP, Raisz LG Rodan GA, eds. Prin-
ciples of bone biology. San Diego, CA: Academic, 1996:917–933.
6. Dawson-Hughes B, Harris S, Finnerman S. Calcium absorption on
high and low calcium intake in relation to vitamin D receptor
genotype. J Clin Endocrinol Metab 1995;80:3657–3661.
7. Gennari L, Becherini L, Masi L, Gonnelli S, Cepollaro C, Martini S,
Mansani R, Brandi ML. Vitamin D receptor genotypes and
intestinal calcium absorption in postmenopausal women. Calcif
Tissue Int 1997;61:460–463.
8. Howard H, Nguyen T, Morrison N, Watanabe T, Sambrook P,
Eisman J, Kelly PJ. Genetic influences on bone density: physiologi-
cal correlates of vitamin D receptor gene alleles in premeno-
pausal women. J Clin Endocrinol Metab 1995;80:2800–2805.
9. World Health Organization. Assessment of fracture risk and its
application to screening for postmenopausal osteoporosis. Tech-
nical report no. 843. Geneva: World Health Organization, 1994.
0. Uitterlinden AG, Pols HAP, Burger H, Huang Q, Van Daele PLA,Van
Duijn CM, Hofman A, Birkenhager JC, Van leeuwen JPTM. A large
population-based study of the association of vitamin D receptor
gene polymorphisms with bone mineral density. J Bone Miner Res
3
1
5
61–567.
7. Ralston SH. The genetics of osteoporosis. Q J Med 1997;90:247–
51.
1
2
3
3
2
8. Riggs BL, Nguyen TV, Melton LJ, Morrison NA, O’Fallon WM, Kelly
PJ, Egan KS, Sambrook PN, Muhs JM, Eisman JA. The contribu-
tion of vitamin D receptor alleles to the determination of bone
mineral density in normal and osteoporotic women. J Bone Miner
Res 1995;10:991–996.
9. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Seist G.
Segregation analysis and variance components analysis of bone
mineral density in healthy families. J Bone Miner Res 1995;10:
1
996;11:1241–1248.
3
2
2
1. Peltekova V, Cole DEC, Hawker G, Pavlova, AG, Rubin LA.
Improved method for direct haplotyping at the vitamin D3 receptor
locus. Clin Biochem 1998;31:191–194.
2. Rubin LA, Hawker GA, Cole DEC, Peltekova V, Fielding L, Ridout R.
Determinants of peak bone mass: clinical and genetic analyses in
a young female Canadian cohort. J Bone Miner Res 1997;
2
017–2022.
4
4
0. Eisman JA. Vitamin D receptor gene alleles and osteoporosis: an
affirmative view. J Bone Miner Res 1995;10:1289–1293.
1. Peacock M. Vitamin D receptor gene alleles and osteoporosis: a
contrasting view. J Bone Miner Res 1995;10:1294–1297.
4
:633–643.
2
2
3. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic
factor in primary biliary cirrhosis. Gut 1979;20:137–140.
4. Atkinson M, Nordin BEC, Sherlock S. Malabsorption and bone
disease in prolonged obstructive jaundice. Q J Med 1956;99:299–
42. Marshall D, Johnell O, Wedel H. Meta-analysis of how well
measures of bone mineral density predict occurrence of osteopo-
rotic fractures. BMJ 1996; 312:1254–1259.
3
12.
43. Torres A, Machado M, Concepcion MT, Martin N, Lorenzo V,
Henandez D, Rodriguez AP, Rodriguez A, De Bonis E, Gonzalez-
Posada JM, Hernandez A, Salido E. Influence of vitamin D
receptor genotype on bone mass changes after renal transplanta-
tion. Kidney Int 1996;50:1726–1733.
2
5. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe
HJ. Osteoporosis in primary biliary cirrhosis effects of 25-
hydroxyvitamin D3 treatment. Gastroenterology 1982;83:97–
1
02.
2
2
6. Hay EJ. Bone disease in cholestatic liver disease. Gastroenterol-
ogy 1995;108:276–283.
7. Mitchison HC, Malcolm AJ, Bassendine MF, James OFW. Meta-
bolic bone disease in primary biliary cirrhosis at presentation.
Gastroenterology 1988;94:463–470.
44. Gough A, Sambrook P, Devlin J, Lilley L, Huisoon A, Betteridge J,
Franklyn J, Nguyen T, Morrison N, Eisman J, Emery P. Effect of
vitamin D receptor gene alleles on bone loss in early rheumatoid
arthritis. J Rheumatol 1998;25:864–868.
2
2
3
8. Aguilar JI, Radick J, Kodali V, Levis S, Altman R, Sadowski JA,
Reddy KR, Jeffers LJ, Parker T, Schill ER. Bone disease and
plasma vitamin K levels in PBC patients (abstr). Gastroenterology
Received January 27, 1999. Accepted September 17, 1999.
Address requests for reprints to: Laurence A. Rubin, M.D., 60
Grosvenor Street, Suite 416, Toronto, Ontario M5S 1B6, Canada.
e-mail: laurence.rubin@swchsc.on.ca.
1
993;104:A868.
9. Cuthbert JA, Pak CYC, Zerwekh JE, Glass KD, Combes B. Bone
disease in primary biliary cirrhosis: increased bone resorption
and turnover in the absence of osteoporosis or osteomalacia.
Hepatology 1984;4:1–8.
0. Vassilopoulou-Sellin R, Rey-Bear N, Oyedeji CO. Bilirubin as an
inhibitor of cartilage metabolism: effect on avian chondrocyte
proliferation in cell culture. J Bone Miner Res 1990;5:769–774.
Supported by the Dairy Farmers of Canada.
The authors thank Drs. Wade Blanchard and David Hamilton,
Department of Statistics, Dalhousie University, Halifax, Nova
Scotia, Canada, for assistance in the statistical analyses, and L.
Sauv e´ for assistance in preparation of the manuscript.